Hyoscyamine Dosing for IBS
For adults with IBS, use hyoscyamine 0.125-0.25 mg orally every 4 hours as needed, not exceeding 1.5 mg in 24 hours, taken preferably before meals or when anticipating symptom onset. 1
Specific Dosing Regimens
Adults and Adolescents (≥12 years)
Oral Solution (Hyosyne Drops):
- 1-2 mL every 4 hours as needed
- Maximum: 12 mL per 24 hours 1
Elixir Formulation:
- 1-2 teaspoonfuls (5-10 mL) every 4 hours as needed
- Maximum: 12 teaspoonfuls per 24 hours 1
Pediatric Dosing (2 to <12 years)
Dosing is weight-based:
- 10 kg (22 lb): 1/4 teaspoon (1.25 mL)
- 20 kg (44 lb): 1/2 teaspoon (2.5 mL)
- 40 kg (88 lb): 3/4 teaspoon (3.75 mL)
- 50 kg (110 lb): 1 teaspoon (5 mL)
- Maximum: 6 teaspoonfuls per 24 hours 1
Clinical Context and Positioning
The 2022 AGA guidelines conditionally suggest using antispasmodics (including hyoscyamine) for IBS, though the evidence quality is low 2. Notably, hyoscyamine is NOT specifically mentioned in the 2022 AGA guidelines—only hyoscine (scopolamine), dicyclomine, and peppermint oil are listed as available antispasmodics in the United States 2.
However, hyoscyamine remains FDA-approved and widely used in clinical practice for IBS 1, 3.
Practical Prescribing Strategy
Intermittent use is preferred over scheduled dosing:
- Use before meals when postprandial symptoms are predictable 4
- Use as needed during acute pain episodes rather than continuously 4
- For unpredictable severe pain episodes, sublingual hyoscyamine provides rapid relief 4
- Consider prophylactic dosing before activities where symptoms would be particularly problematic 4
Important Caveats
Anticholinergic effects limit use in IBS-C:
- Hyoscyamine's anticholinergic properties can worsen constipation 2
- Avoid regular use in constipation-predominant IBS 2
- Best suited for IBS-D or IBS-M subtypes
Common adverse effects include dry mouth, dizziness, and blurred vision, though serious adverse events are rare 2.
Onset and duration:
Dosage Adjustment Approach
Start with the lower end of the dosing range and adjust based on symptom severity and tolerability 1. The goal is to use the minimum effective dose for the shortest duration necessary to control symptoms, rather than continuous long-term therapy 4.